ESGO–SIOPE guidelines for the management of adolescents and young adults with non-epithelial ovarian cancers

The European Society of Gynaecological Oncology and the European Society for Paediatric Oncology jointly developed clinically relevant and evidence-based guidelines for the management of adolescents and young adults aged 15 to 25 years with non-epithelial ovarian cancers, including malignant ovarian...

Full description

Saved in:
Bibliographic Details
Published in:The lancet oncology Vol. 21; no. 7; pp. e360 - e368
Main Authors: Sessa, Cristiana, Schneider, Dominik T, Planchamp, François, Baust, Katja, Braicu, Elena Ioana, Concin, Nicole, Godzinski, Jan, McCluggage, W Glenn, Orbach, Daniel, Pautier, Patricia, Peccatori, Fedro A, Morice, Philippe, Calaminus, Gabriele
Format: Journal Article
Language:English
Published: London Elsevier Ltd 01.07.2020
Elsevier Limited
Subjects:
ISSN:1470-2045, 1474-5488, 1474-5488
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The European Society of Gynaecological Oncology and the European Society for Paediatric Oncology jointly developed clinically relevant and evidence-based guidelines for the management of adolescents and young adults aged 15 to 25 years with non-epithelial ovarian cancers, including malignant ovarian germ cell tumours, sex cord-stromal tumours, and small cell carcinoma of the ovary of hypercalcaemic type. The developmental process of these guidelines is based on a systematic literature review and critical appraisal process involving an international multidisciplinary developmental group consisting of experts from relevant disciplines (paediatric oncology, paediatric surgery, medical oncology, pathology, psycho-oncology, gynaecological oncology, and reproductive endocrinology). Given the specific and often complex issues involved in treating this group of patients, fertility sparing surgery and decrease of acute and long-term toxicities from treatment were important criteria for guidelines definition. Prior to publication, the guidelines were reviewed by 54 independent international practitioners in cancer care delivery.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ObjectType-Review-3
content type line 23
ISSN:1470-2045
1474-5488
1474-5488
DOI:10.1016/S1470-2045(20)30091-7